{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:24:04Z","timestamp":1760984644401},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Solvay foundation"},{"name":"Trommsdorff"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.atherosclerosis.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T02:46:24Z","timestamp":1347504384000},"page":"166-172","source":"Crossref","is-referenced-by-count":21,"title":["Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation"],"prefix":"10.1016","volume":"225","author":[{"given":"Stephan H.","family":"Schirmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan B.G.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Faas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Custodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/ATVBAHA.111.226100","article-title":"Triglycerides and heart disease","volume":"31","author":"Goldberg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib2","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a postprandial phenomenon","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yjmcc.2008.10.029","article-title":"Suppression of inflammatory signaling in monocytes from patients with coronary artery disease","volume":"46","author":"Schirmer","year":"2009","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/ATVBAHA.107.159749","article-title":"Leukocyte activation by triglyceride-rich lipoproteins","volume":"28","author":"Alipour","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/ATVBAHA.110.215434","article-title":"CD11c\/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1","volume":"31","author":"Gower","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2004.07.004","article-title":"Activation of leukocytes by postprandial lipemia in healthy volunteers","volume":"177","author":"van Oostrom","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2006.02.012","article-title":"Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review","volume":"189","author":"Balk","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1194\/jlr.M200361-JLR200","article-title":"Differential modulation of toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids","volume":"44","author":"Lee","year":"2003","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib14","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCRESAHA.108.171827","article-title":"Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice","volume":"102","author":"Schirmer","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.amjcard.2010.03.062","article-title":"Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction","volume":"106","author":"Azab","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib16","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage","volume":"332","author":"Morrow","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.RES.33.6.633","article-title":"A\u00a0proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins","volume":"33","author":"Zilversmit","year":"1973","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI114024","article-title":"Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?","volume":"83","author":"Chung","year":"1989","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/cyto.1997.0289","article-title":"Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications","volume":"10","author":"Petrovsky","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/01.ATV.0000021759.08060.63","article-title":"Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients","volume":"22","author":"Sampson","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib23","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib24","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMra1008153","article-title":"n-3 fatty acids in cardiovascular disease","volume":"364","author":"De Caterina","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M200282-JLR200","article-title":"Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance","volume":"44","author":"Park","year":"2003","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0022-2275(20)38424-8","article-title":"Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids","volume":"29","author":"Harris","year":"1988","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.ATV.0000200226.53994.09","article-title":"Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells","volume":"26","author":"Zhang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2010.12.013","article-title":"Effect of n-3 fatty acids and statins on oxidative stress in statin-treated hypercholestorelemic and normocholesterolemic women","volume":"217","author":"Carrepeiro","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/qjmed\/hch130","article-title":"Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease","volume":"97","author":"Rumley","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cvr\/cvn007","article-title":"Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2","volume":"78","author":"Tuomisto","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/ajcn\/84.6.1290","article-title":"Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45\u201370 y: the OPTILIP study","volume":"84","author":"Griffin","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib33","first-page":"1126","article-title":"(n-3) fatty acid supplementation in moderately hypertriglyceridemic adults changes postprandial lipid and apolipoprotein B responses to a standardized test meal","volume":"129","author":"Tinker","year":"1999","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.atherosclerosis.2012.09.002_bib34","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ajcn\/71.4.914","article-title":"Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids","volume":"71","author":"Westphal","year":"2000","journal-title":"Am J Clin Nutr"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012005916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012005916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T21:29:03Z","timestamp":1643405343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915012005916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0021915012005916"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.09.002","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}